Key result
Low ankle-brachial index (≤0.9) after first-ever ischemic stroke was associated with increased risk of baseline cognitive impairment (RR 1.98; 95% CI 1.24-3.16) and persistently lower scores over time.
Why the study?
Low ankle-brachial index is a marker for generalized atherosclerosis and cognitive decline in the general population, but its impact on cognitive function up to 3 years after first-ever ischemic stroke needed evaluation.
Does low ankle-brachial index (ABI ≤0.9) predict reduced cognitive function in patients with mild to moderate first-ever ischemic stroke?
Cohort (n=325)
Does low ankle-brachial index (ABI ≤0.9) predict reduced cognitive function in patients with mild to moderate first-ever ischemic stroke?
Relative Risk: 1.98 (95% CI 1.24–3.16)
In patients with mild to moderate first-ever ischemic stroke, a low ankle-brachial index (≤0.9) is associated with reduced cognitive function over a 3-year follow-up.
Low ABI signals higher cognitive impairment risk after mild-moderate stroke; observational data leaves open whether ABI screening should guide practice.
Introduction: Low ankle-brachial index (ABI) ≤0. 9 is a marker for generalized atherosclerosis and a risk factor for cognitive decline in the general population. Objective: To evaluate the impact of ABI ≤0.9 on cognitive function up to 3 years after first-ever ischemic stroke. Methods: Data was used from the "PROspective Cohort with Incident Stroke-Berlin" (PROSCIS-B; NCT01363856). ABI was measured at baseline and categorized into normal (1.4-0.9) vs. low (≤0.9). Cognitive function was assessed with the Montreal Cognitive Assessment (MoCA) and the Mini-Mental-State-Examination (MMSE) at baseline and with the Telephone Interview for Cognitive Status-modified (TICS-m) at 1-3 years of follow-up. We performed confounder adjusted generalized linear models (GLM) to calculate relative risks (RR) for cognitive impairment at baseline (MMSE≤26; MoCA≤25) and linear mixed models (LMM) to estimate the impact of low ABI on TICS-m over time. Results: We included 325 patients [mean age: 66 (SD = 13); 38% female, median NIHSS = 2 (IQR = 1-4), ABI≤0.9: 59 (18%)]. Patients with low ABI were at increased risk of cognitive impairment at baseline (adjusted RR for MoCA≤25 = 1.98; 95%-CI:1.24 to 3.16). TICS-m scores were consistently lower over time in patients with low ABI (adjusted ß = -1.96; 95%-CI:-3.55 to -0.37). Independent of ABI, cognitive function did not decline over time (adjusted ß:0.29; 95%-CI:-0.06 to 0.64). Conclusion: In patients with mild to moderate first-ever ischemic stroke, low ABI is associated with reduced cognitive function over a 3-year follow-up. Study Registration: https://clinicaltrials.gov; Unique identifier: NCT01363856.
No takes yet. Share an insight, caveat, or question.
Stillfried et al. (2022) conducted a cohort in First-ever ischemic stroke (n=325). Low ankle-brachial index (≤0.9) vs. Normal ankle-brachial index (1.4-0.9) was evaluated on Cognitive impairment at baseline (MoCA≤25) (RR 1.98, 95% CI 1.24-3.16). Low ankle-brachial index (≤0.9) after first-ever ischemic stroke was associated with increased risk of baseline cognitive impairment (RR 1.98; 95% CI 1.24-3.16) and persistently lower scores over time.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: